Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romero

Showing results (141-150 of 53,381) with videos related to

Pageof 5,339
Sort By:
Nature Reviews. Clinical Oncology|September 28, 2021
Benefit with daratumumab maintenanceDiana Romero
American Journal of Obstetrics and Gynecology|March 9, 2022
Leaders in Academic Medicine: a profile of Arthur S. Levine, MDRoberto Romero
Nature Reviews. Clinical Oncology|January 28, 2022
Survival benefit with second-line combination in endometrial cancerDiana Romero
Nature Reviews. Clinical Oncology|May 3, 2020
Acalabrutinib - a new option in CLLDiana Romero
Nature Reviews. Clinical Oncology|May 26, 2021
Cemiplimab is a new option in BCCDiana Romero
Revista Mexicana De Sociologia|January 1, 1976
[An evaluation of the under-registry of childhood mortality]Romero Car
Studies in History and Philosophy of Science|December 13, 2016
Can the behavioral sciences self-correct? A social epistemic studyFelipe Romero
Nature Reviews. Clinical Oncology|March 21, 2017
Urological cancer: Unravelling intertwined second-line optionsDiana Romero
Boletin De La Oficina Sanitaria Panamericana. Pan American Sanitary Bureau|January 1, 1978
[Epidemiologic study and surveillance of pesticide poisoning]A Romero
Nature Reviews. Clinical Oncology|October 10, 2023
Dabrafenib-trametinib moves to the first line in low-grade gliomaDiana Romero
Pageof 5,339

Showing results (141-150 of 53,381) with videos related to

Sort By:
Pageof 5,339
Nature Reviews. Clinical Oncology|September 28, 2021
Benefit with daratumumab maintenanceDiana Romero
American Journal of Obstetrics and Gynecology|March 9, 2022
Leaders in Academic Medicine: a profile of Arthur S. Levine, MDRoberto Romero
Nature Reviews. Clinical Oncology|January 28, 2022
Survival benefit with second-line combination in endometrial cancerDiana Romero
Nature Reviews. Clinical Oncology|May 3, 2020
Acalabrutinib - a new option in CLLDiana Romero
Nature Reviews. Clinical Oncology|May 26, 2021
Cemiplimab is a new option in BCCDiana Romero
Revista Mexicana De Sociologia|January 1, 1976
[An evaluation of the under-registry of childhood mortality]Romero Car
Studies in History and Philosophy of Science|December 13, 2016
Can the behavioral sciences self-correct? A social epistemic studyFelipe Romero
Nature Reviews. Clinical Oncology|March 21, 2017
Urological cancer: Unravelling intertwined second-line optionsDiana Romero
Boletin De La Oficina Sanitaria Panamericana. Pan American Sanitary Bureau|January 1, 1978
[Epidemiologic study and surveillance of pesticide poisoning]A Romero
Nature Reviews. Clinical Oncology|October 10, 2023
Dabrafenib-trametinib moves to the first line in low-grade gliomaDiana Romero
Pageof 5,339